Standard BioTools Reports Fourth Quarter and Full Year 2022
Fourth quarter 2022 GAAP revenues of $27.0 million; Core product and service revenues of $26.8 million, representing 8.3% sequential growth; Full year GAAP...
Source: globenewswire.com
Page 7 - Standard Biotool News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Standard Biotool. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Standard Biotool Today - Breaking & Trending Today
Ascendas Genomics Receives NMPA Approval for Use of Standard BioTools Microfluidics Technology to Advance the Development of Molecular Diagnostics in China
13.10.2022 - SOUTH SAN FRANCISCO, Calif., Oct. 13, 2022 (GLOBE NEWSWIRE) - Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health – today announced that Ascendas Genomics has received ... Seite 1
Source: wallstreet-online.de
Standard BioTools Announces Collaboration Agreement With Visikol to Offer Multiplex Imaging Mass Cytometry Services
South San Francisco, Calif. (PRWEB) October 11, 2022 -- SOUTH SAN FRANCISCO, Calif., October 11, 2022 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB),
Source: prweb.com
Standard BioTools : Announces Second Quarter 2022 Financial Results and Provides Strategic Update - Form 8-K
Standard BioTools Announces Second Quarter 2022 Financial Results and Provides Strategic Update Second quarter revenue of $18.8 million Completed $250 million... | August 8, 2022
Source: marketscreener.com
Reviewing Standard BioTools (LAB) and The Competition
Standard BioTools (NASDAQ:LAB – Get Rating) is one of 42 publicly-traded companies in the “Analytical instruments” industry, but how does it weigh in compared to its peers? We will compare Standard BioTools to related companies based on the strength of its profitability, earnings, analyst recommendations, risk, dividends, valuation and institutional ownership. Profitability This table compares […]
Source: etfdailynews.com